KR20040021598A - Ｕｖｂ-유발 피부손상 방지 방법 - Google Patents

Ｕｖｂ-유발 피부손상 방지 방법 Download PDF

Info

Publication number
KR20040021598A
KR20040021598A KR10-2003-7013393A KR20037013393A KR20040021598A KR 20040021598 A KR20040021598 A KR 20040021598A KR 20037013393 A KR20037013393 A KR 20037013393A KR 20040021598 A KR20040021598 A KR 20040021598A
Authority
KR
South Korea
Prior art keywords
tsp
subject
uvb
induced
wrinkles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR10-2003-7013393A
Other languages
English (en)
Korean (ko)
Inventor
기이치로 야노
제이. 데트마 마이클
Original Assignee
더 제너럴 하스피탈 코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 더 제너럴 하스피탈 코포레이션 filed Critical 더 제너럴 하스피탈 코포레이션
Publication of KR20040021598A publication Critical patent/KR20040021598A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR10-2003-7013393A 2001-04-13 2002-04-11 Ｕｖｂ-유발 피부손상 방지 방법 Ceased KR20040021598A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28387401P 2001-04-13 2001-04-13
US60/283,874 2001-04-13
PCT/US2002/011403 WO2002083088A1 (en) 2001-04-13 2002-04-11 Methods of preventing uvb-induced skin damage

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020087028640A Division KR20080108366A (ko) 2001-04-13 2002-04-11 Ｕｖｂ-유발 피부손상 방지 방법

Publications (1)

Publication Number Publication Date
KR20040021598A true KR20040021598A (ko) 2004-03-10

Family

ID=23087934

Family Applications (2)

Application Number Title Priority Date Filing Date
KR10-2003-7013393A Ceased KR20040021598A (ko) 2001-04-13 2002-04-11 Ｕｖｂ-유발 피부손상 방지 방법
KR1020087028640A Ceased KR20080108366A (ko) 2001-04-13 2002-04-11 Ｕｖｂ-유발 피부손상 방지 방법

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020087028640A Ceased KR20080108366A (ko) 2001-04-13 2002-04-11 Ｕｖｂ-유발 피부손상 방지 방법

Country Status (8)

Country Link
US (1) US6712617B2 (https=)
EP (1) EP1377253A4 (https=)
JP (1) JP2004526758A (https=)
KR (2) KR20040021598A (https=)
CN (1) CN100340287C (https=)
CA (1) CA2446093A1 (https=)
TW (1) TWI233361B (https=)
WO (1) WO2002083088A1 (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040266706A1 (en) * 2002-11-05 2004-12-30 Muthiah Manoharan Cross-linked oligomeric compounds and their use in gene modulation
TWI312681B (en) * 2001-02-01 2009-08-01 Novel physiologically active substance
TWI334866B (en) * 2002-05-29 2010-12-21 Mercian Corp Novel physiologically active substances
US7238370B2 (en) * 2002-06-14 2007-07-03 Rosenberg E William Method and composition to prevent and treat photoaging of skin
EP1559429A4 (en) * 2002-06-25 2009-09-09 Shiseido Co Ltd AGAIN AGING AGING
CA2494536C (en) * 2002-07-31 2011-10-04 Mercian Corporation A 12-membered ring macrolide active substance
JP4459051B2 (ja) * 2002-07-31 2010-04-28 メルシャン株式会社 新規生理活性物質
US7458982B2 (en) 2002-10-04 2008-12-02 Photokinetix, Inc. Photokinetic delivery of biologically active substances using pulsed incoherent light
DE10254214A1 (de) * 2002-11-20 2004-06-09 Beiersdorf Ag Oligoribonukleotide zur Behandlung von degenerativen Hauterscheinungen durch RNA-Interferenz
BR0316746A (pt) * 2002-11-29 2005-10-18 Mercian Corp Método de produção do composto macrolida 11107d, linhagem streptomyces sp.ab-1704 (ferm bp-8551), linhagem mortierella sp. f1529 (ferm bp-8547) ou linhagem f-1530 (ferm bp-8548), e linhagem ab-1896 (ferm bp-8550)
US20050281761A1 (en) * 2004-04-01 2005-12-22 Michael Detmar Methods of preventing UVB-induced skin damage
US20050276762A1 (en) * 2004-06-15 2005-12-15 Tapas Das Topical compositions containing 5'-adenosine-diphosphate ribose
WO2006042114A1 (en) * 2004-10-06 2006-04-20 Cook, Inc. Emboli capturing device having a coil and method for capturing emboli
EP3340511B1 (en) 2004-10-12 2022-11-30 TQ Delta, LLC Resource sharing in a telecommunications enviroment
US9084734B2 (en) 2005-05-05 2015-07-21 Danisco Us Inc. Peptide personal care compositions and methods for their use
EP1938827A4 (en) * 2005-09-16 2010-07-21 Shiseido Co Ltd NEW HEMMER OF THE EXPRESSION OF VASCULAR ENDOTHEL GROWTH FACTOR
TWI428143B (zh) 2006-01-18 2014-03-01 Gen Hospital Corp 增加淋巴功能之方法
AU2007257055A1 (en) 2006-04-12 2007-12-13 Aware, Inc. Packet retransmission and memory sharing
WO2008005533A2 (en) * 2006-07-06 2008-01-10 Aaron Thomas Tabor Compositions and methods for genetic modification of cells having cosmetic function to enhance cosmetic appearance
WO2008020584A1 (en) * 2006-08-14 2008-02-21 Eisai R & D Management Co., Ltd. Stable lyophilized preparation
US7790887B2 (en) * 2007-01-29 2010-09-07 Eisai R&D Management Co., Ltd. Macrolide compound in solid form, process for preparation thereof, and pharmaceutical composition containing the same
CN101970012A (zh) 2007-09-14 2011-02-09 日东电工株式会社 药物载体
WO2011008904A1 (en) 2009-07-17 2011-01-20 Tabor Aaron T Compositions and methods for genetic modification of cells having cosmetic function to enhance cosmetic appearance
EP2484359B1 (en) 2009-09-30 2018-07-25 Shiseido Company, Ltd. Heparanase activity inhibitor
US20240189397A1 (en) * 2019-12-24 2024-06-13 Juvena Therapeutics, Inc. Heparin-Associated Polypeptides and Uses Thereof
CN115379850A (zh) 2019-12-24 2022-11-22 裘美娜治疗公司 再生性多肽及其用途
WO2022271466A1 (en) 2021-06-21 2022-12-29 Juvena Therapeutics, Inc. Regenerative polypeptides and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6025334A (en) * 1994-04-28 2000-02-15 Les Laboratoires Aeterna Inc. Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof
BR9809691A (pt) * 1997-05-27 2000-10-03 Sembiosys Genetics Inc Usos de substâncias de óleo
US6372234B1 (en) 1997-05-27 2002-04-16 Sembiosys Genetics Inc. Products for topical applications comprising oil bodies
WO1999026649A1 (en) * 1997-11-25 1999-06-03 Cornell Research Foundation, Inc. Methods and compositions for inhibiting hiv infectivity and blocking chemokine activity
EP1171151A4 (en) * 1999-03-31 2004-08-04 Gen Hospital Corp THROMBOSPONDIN-2 AND THEIR USE
US6673843B2 (en) * 1999-06-30 2004-01-06 Emory University Curcumin and curcuminoid inhibition of angiogenesis

Also Published As

Publication number Publication date
US6712617B2 (en) 2004-03-30
TWI233361B (en) 2005-06-01
WO2002083088A1 (en) 2002-10-24
US20030008821A1 (en) 2003-01-09
JP2004526758A (ja) 2004-09-02
CN1512868A (zh) 2004-07-14
CN100340287C (zh) 2007-10-03
EP1377253A1 (en) 2004-01-07
EP1377253A4 (en) 2008-09-03
KR20080108366A (ko) 2008-12-12
CA2446093A1 (en) 2002-10-24

Similar Documents

Publication Publication Date Title
KR20040021598A (ko) Ｕｖｂ-유발 피부손상 방지 방법
JP5960749B2 (ja) 毛の成長を調節する方法
Hasan et al. Coordinate expression of NGF and α-smooth muscle actin mRNA and protein in cutaneous wound tissue of developing and adult rats
ES2403517T3 (es) Aparato y método de procesamiento de datos
US6773881B2 (en) Methods of modulating hair growth
US20080187543A1 (en) Use of Myostatin (Gdf-8) Antagonists for Improving Wound Healing and Preventing Fibrotic Disease
AU2001253012A1 (en) Methods of modulating hair growth
JPH09509825A (ja) 骨細胞を刺激するための方法および組成物
ES2402672T3 (es) Uso del GDF-5 para el mejoramiento o el mantenimiento del aspecto dérmico
US20100247627A1 (en) Foxn1 and pigmentation
TW200302109A (en) Methods and compositions for the promotion of hair growth utilizing actin binding peptides
CN110997708A (zh) 人bmp7蛋白的变体
US20020048582A1 (en) Methods of modulating angiogenesis
EP0778779B1 (en) Methods of inducing hair growth and coloration
AU2002254588B2 (en) Methods of Preventing UVB-Induced Skin Damage
AU2002254588A1 (en) Methods of Preventing UVB-Induced Skin Damage
CN110023325B (zh) 具有提高的生物活性和降低的对嗜中性粒细胞弹性蛋白酶降解易感性的来源于纤连蛋白的肽
CN120060374A (zh) 用于改善皮肤结构和功能的工程化单纯疱疹病毒载体及其用途
HK40027691A (en) Variants of human bmp7 protein

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20031011

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20070409

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20080129

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20080724

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20080129

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

Patent event date: 20081024

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20080724

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20100630

Appeal identifier: 2008101011196

Request date: 20081024

A107 Divisional application of patent
AMND Amendment
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20081124

PB0901 Examination by re-examination before a trial

Comment text: Amendment to Specification, etc.

Patent event date: 20081124

Patent event code: PB09011R02I

Comment text: Request for Trial against Decision on Refusal

Patent event date: 20081024

Patent event code: PB09011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 20080328

Patent event code: PB09011R02I

Comment text: Amendment to Specification, etc.

Patent event date: 20070409

Patent event code: PB09011R02I

B601 Maintenance of original decision after re-examination before a trial
E801 Decision on dismissal of amendment
PB0601 Maintenance of original decision after re-examination before a trial

Comment text: Report of Result of Re-examination before a Trial

Patent event code: PB06011S01D

Patent event date: 20081231

PE0801 Dismissal of amendment

Patent event code: PE08012E01D

Comment text: Decision on Dismissal of Amendment

Patent event date: 20081231

Patent event code: PE08011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 20081124

Patent event code: PE08011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 20080328

Patent event code: PE08011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 20070409

J301 Trial decision

Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20081024

Effective date: 20100630

PJ1301 Trial decision

Patent event code: PJ13011S01D

Patent event date: 20100630

Comment text: Trial Decision on Objection to Decision on Refusal

Appeal kind category: Appeal against decision to decline refusal

Request date: 20081024

Decision date: 20100630

Appeal identifier: 2008101011196

PC1202 Submission of document of withdrawal before decision of registration

Comment text: [Withdrawal of Procedure relating to Patent, etc.] Withdrawal (Abandonment)

Patent event code: PC12021R01D

Patent event date: 20100803

WITB Written withdrawal of application
J121 Written withdrawal of request for trial
PJ1201 Withdrawal of trial

Patent event code: PJ12011R01D

Patent event date: 20100804

Comment text: Written Withdrawal of Request for Trial

Appeal identifier: 2008101011196

Request date: 20081024

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20100630